Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INSULIN LISPRO-AABC for Type 2 diabetes mellitus: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 25 adverse event reports in the FDA FAERS database where INSULIN LISPRO-AABC was used for Type 2 diabetes mellitus.

Most Reported Side Effects for INSULIN LISPRO-AABC

Side Effect Reports % Deaths Hosp.
Infusion site pain 248 30.3% 0 0
Blood glucose increased 164 20.0% 1 10
Wrong technique in product usage process 115 14.0% 0 1
Injection site pain 109 13.3% 0 0
Drug ineffective 84 10.3% 0 2
Infusion site erythema 48 5.9% 0 0
Blood glucose decreased 37 4.5% 0 1
Infusion site pruritus 31 3.8% 0 0
Infusion site irritation 30 3.7% 0 0
Blood glucose abnormal 24 2.9% 0 2
Hypoglycaemia 23 2.8% 0 6
Glycosylated haemoglobin increased 22 2.7% 1 1
Hyperglycaemia 21 2.6% 0 3
Nausea 21 2.6% 1 2
Infusion site mass 20 2.4% 0 0

Other Indications for INSULIN LISPRO-AABC

Product used for unknown indication (489) Type 1 diabetes mellitus (174) Diabetes mellitus (104) Blood glucose increased (5)

Other Drugs Used for Type 2 diabetes mellitus

INSULIN GLARGINE (41,731) METFORMIN (25,080) DULAGLUTIDE (24,742) SEMAGLUTIDE (17,910) INSULIN LISPRO (16,871) EXENATIDE (16,403) TIRZEPATIDE (14,571) EMPAGLIFLOZIN (12,176) CANAGLIFLOZIN (10,795) PIOGLITAZONE (8,418)

Related Pages

INSULIN LISPRO-AABC Full Profile All Type 2 diabetes mellitus Drugs INSULIN LISPRO-AABC Demographics INSULIN LISPRO-AABC Timeline